SCHEMBL2934893

SCHEMBL2934893

Nc1nccc(Oc2ccc(NC(=O)O)cc2F)c1N

nearest known ligand 0.54

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 0.54
KDR P35968 3/20 0.54
RET P07949 1/20 0.54
KIT P10721 1/20 0.54
PDGFRA P16234 1/20 0.54
FLT3 P36888 1/20 0.54
CYP3A4 P08684 3/20 0.49
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4463126 0.86 MET (0.42) METKDRRETKITPDGFRA
SCHEMBL2928469 0.84 MET (0.49) METKDRRETKITPDGFRA
SCHEMBL2928468 0.84 MET (0.49) METKDRRETKITPDGFRA
SCHEMBL3753851 0.84 MET (0.49) METKDRRETKITPDGFRA
SCHEMBL30146837 0.84 MET (0.49) METKDRRETKITPDGFRA
SCHEMBL1794175 0.84 GRM4 (0.43) METKDRRETKITPDGFRA
SCHEMBL18256939 0.81 MET (0.82) METKDRRETKITPDGFRA
SCHEMBL27171642 0.81 MET (0.54) METKDRRETKITPDGFRA
SCHEMBL2928213 0.80 PDGFRA (0.44) METKDRKITPDGFRAFLT3
SCHEMBL1137330 0.80 MET (0.73) METKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4339196-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR LG Chem, Ltd. (KR) 2024-03-20 EP disclosed
EP-4339197-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR Lg Chem, Ltd. (KR) 2024-03-20 EP disclosed
WO-2022270980-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR 주식회사 엘지화학 2022-12-29 WO disclosed
WO-2022270979-A1 NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR 주식회사 엘지화학 2022-12-29 WO disclosed
WO-2021043217-A1 COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF 中国科学院上海药物研究所 2021-03-11 WO disclosed
EP-2229391-A1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE Cancer Research Technology Limited (GB) 2010-09-22 EP disclosed
WO-2009077766-A1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2009-06-25 WO disclosed